Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes - Kodera, R; Shikata, K; Kataoka, H U (Diabetologia, 2011)
et al.